ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

26 hedge funds and large institutions have $2.94M invested in Oramed Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
5
Reduced
5
Closed
3
Calls
$30K
Puts
$1K
Net Calls
+$29K
Net Calls Change
+$29K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$568K
2
Jane Street
2
Jane Street
New York
$155K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$60K
4
BlackRock
4
BlackRock
New York
$267K
5
Simplex Trading
5
Simplex Trading
Illinois
$6K

Top Sellers

1
SM
1
Sabby Management
Florida
$1.27M
2
Deutsche Bank
2
Deutsche Bank
Germany
$0
3
DCM
3
DAFNA Capital Management
California
$57K
4
Wells Fargo
4
Wells Fargo
California
$18K
5
SWM
5
SeaCrest Wealth Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GT
26
Glenmede Trust
Pennsylvania
$71 – – –
Deutsche Bank
27
Deutsche Bank
Germany
– -$38K -10,527 Closed
SWM
28
SeaCrest Wealth Management
New York
– -$5K -1,500 Closed
Nordea Investment Management
29
Nordea Investment Management
Sweden
– -$2K -500 Closed
1
2